The tumor suppressor gene TP53 is mutated in ~50% of human cancers, and therefrom, derived protein p53 plays a major role in the response of malignant as well as non-transformed cells to many anticancer therapeutics, particularly those that cause DNA damage [66]. The gene discussed is TP53; the disease is cancer.